The incidence of Hepatitis B in Canada has been stable, forecasted consistently at 13.5 cases per hundred thousand persons from 2024 to 2028, reflecting no expected variation. For comparative purposes, the incidence rate leading up to 2023 maintained similar levels. This suggests strong vaccination programs and public health policies might be effectively stabilizing the incidence rate without significant natural increases or declines annually.
Future trends to watch for:
- Implementation of new vaccines or booster programs that could affect incidence rates.
- Potential shifts in policy or healthcare strategies that may alter the long-term trend.
- Demographic changes that could influence susceptibility or exposure rates.
